Internal Medicine, Endocrinology, Diabetes, & Metabolism · Philadelphia, PA
NPI
1932381209
Since 2007
Specialty
Internal Medicine, Endocrinology, Diabetes, & Metabolism
Code 207RE0101X
Group practices
2
Medicare group memberships
Hospitals
6
Hospital affiliations
3400 Civic Center Boulevard, West Pavilion 4th Floor
Philadelphia, PA, 19104
Phone (215) 662-2300
Groups this clinician bills Medicare through
Medicare paid, 2024
$63K
1,206 services
Medicare patients, 2024
508
Average age 73
Drug cost, 2024
$1.6M
3,142 prescriptions
Company payments, 2025
$36.13
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Christina M Mitchell was code G2211 (visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's), 375 times for 334 patients. In total Christina M Mitchell billed 1,206 services in 11 codes, and Medicare paid $63K.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2013-04-23.
| Code | Setting | Services | Patients | Paid per service | Medicare paid |
|---|---|---|---|---|---|
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 375 | 334 | $12.32 | $4,621 |
| 99214 Office E&M - Established | Office | 172 | 164 | $69.14 | $12K |
| 99215 Office E&M - Established | Office | 145 | 128 | $100.87 | $15K |
| 99214 Office E&M - Established | Facility | 142 | 116 | $68.54 | $9,733 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Facility | 129 | 113 | $12.75 | $1,645 |
| 99205 Office E&M - New | Office | 54 | 54 | $131.00 | $7,074 |
| 99215 Office E&M - Established | Facility | 44 | 41 | $112.86 | $4,966 |
| 95251 Test - Miscellaneous | Office | 41 | 37 | $27.09 | $1,111 |
| 95251 Test - Miscellaneous | Facility | 37 | 26 | $27.14 | $1,004 |
| 99204 Office E&M - New | Facility | 15 | 15 | $108.20 | $1,623 |
| 99222 Hospital E&M - Initial | Facility | 14 | 14 | $105.80 | $1,481 |
| 99205 Office E&M - New | Facility | 11 | 11 | $136.00 | $1,496 |
By year: 2022 $51K for 649 services; 2023 $52K for 647 services; 2024 $63K for 1,206 services.
Medicare prescription drug claims, 2024
In 2024, the drug Christina M Mitchell prescribed most often to Medicare patients was Synthroid (Levothyroxine Sodium), with 406 prescriptions and refills. In total Christina M Mitchell wrote 3,142 Medicare prescriptions that cost $1.6M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Synthroid Levothyroxine Sodium | 406 | 1,070 | 116 | $43K |
| Levothyroxine Sodium Generic | 280 | 753 | 92 | $3,654 |
| Levoxyl Levothyroxine Sodium | 242 | 612 | 61 | $9,379 |
| Metformin Hcl Er Metformin Hcl | 172 | 472 | 63 | $2,979 |
| Ozempic Semaglutide | 146 | 278 | 45 | $260K |
| Mounjaro Tirzepatide | 146 | 196 | 36 | $202K |
| Alendronate Sodium Generic | 131 | 331 | 42 | $2,465 |
| Teriparatide Generic | 82 | 82 | 13 | $191K |
| Lantus Solostar Insulin Glargine,hum.Rec.Anlog | 81 | 202 | 31 | $13K |
| Nano 2nd Gen Pen Needle Pen Needle, Diabetic | 78 | 220 | 33 | $11K |
| Metformin Hcl Generic | 66 | 166 | 23 | $803 |
| Liothyronine Sodium Generic | 66 | 164 | 18 | $2,308 |
| Forteo Teriparatide | 65 | 67 | Under 11 | $244K |
| Ultra-Fine Mini Pen Needle Pen Needle, Diabetic | 60 | 181 | 22 | $3,848 |
| Jardiance Empagliflozin | 55 | 149 | 18 | $83K |
Brand drugs: 1,734 claims; generic drugs: 1,172 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Christina M Mitchell $36.13 ($36.13 in general payments such as food, travel and fees) from 1 company. The largest payer was Abbott Laboratories with $36.13.
| Company | Payments | Amount |
|---|---|---|
| Abbott Laboratories ABT | 2 | $36.13 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.